Biogen Urges Justices To Review MS Drug Patent Ruling
Biogen has urged the U.S. Supreme Court to revive its patent on the blockbuster multiple sclerosis drug Tecfidera, saying the Federal Circuit invalidated it using an improper rule not found in...To view the full article, register now.
Already a subscriber? Click here to view full article